![Robert F. Roscigno](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert F. Roscigno
President chez Robert F. Roscigno Phd Consulting LLC
Postes actifs de Robert F. Roscigno
Sociétés | Poste | Début | Fin |
---|---|---|---|
Robert F. Roscigno Phd Consulting LLC | President | - | - |
Historique de carrière de Robert F. Roscigno
Anciens postes connus de Robert F. Roscigno
Sociétés | Poste | Début | Fin |
---|---|---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01/12/2017 | 01/07/2020 |
Vero Biotech LLC
![]() Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | 01/01/2009 | 01/09/2015 |
Lung Biotechnology PBC
![]() Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Directeur des opérations | 01/03/2005 | 01/07/2007 |
President | 01/03/2005 | 01/07/2007 | |
UNITED THERAPEUTICS CORPORATION | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | - | - |
Formation de Robert F. Roscigno
Duke University | Doctorate Degree |
Trinity College (Connecticut) | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Corporate Officer/Principal | 3 |
President | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
Entreprise privées | 4 |
---|---|
Vero Biotech LLC
![]() Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Lung Biotechnology PBC
![]() Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Health Technology |
Robert F. Roscigno Phd Consulting LLC | |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
- Bourse
- Insiders
- Robert F. Roscigno
- Expérience